King Inventory Work-Down Plan Goal Is 1.5 Months Of On-Hand Product
This article was originally published in The Pink Sheet Daily
Executive Summary
Amendments to inventory management agreements with wholesalers are aimed at reducing levels to 1.5 months by the end of March. Work-down announcement accompanies King’s restatement of financials; Mylan deal remains up in the air with one week to go before walk-away date.
You may also be interested in...
Reductions In King Wholesale Inventory Drive Q2 Branded Pharma Sales
King Pharmaceuticals is attributing a rebound in branded pharmaceutical sales during the second quarter in part to lower wholesaler inventories
Reductions In King Wholesale Inventory Drive Q2 Branded Pharma Sales
King Pharmaceuticals is attributing a rebound in branded pharmaceutical sales during the second quarter in part to lower wholesaler inventories
Altace Sales Declines Reflect King's Inventory Workdown Program
Wholesaler inventory reductions of the ACE inhibitor totaled $180 mil. in value in 2004, representing almost all of the 35% decline in Altace sales during the year. Wholesale inventory reductions for Altace and Sonata are continuing as King aims for an on-hand supply of 1.5 months.